Overcoming Resistance to Immunotherapy by Targeting GPR84 in Myeloid-Derived Suppressor Cells

The authors found that GPR84 was prominently expressed on myeloid-derived suppressor cells in clinical samples and tumor mouse models, which drove the immunosuppression on CD8+T cells by inhibiting PD-L1 degradation in lysosomes.